Lineage Cell Therapeutics, Inc.·4

Nov 26, 4:55 PM ET

Samuel George A. III 4

4 · Lineage Cell Therapeutics, Inc. · Filed Nov 26, 2024

Insider Transaction Report

Form 4
Period: 2024-11-26
Samuel George A. III
General Counsel and Secretary
Transactions
  • Purchase

    Common Shares

    2024-11-26$0.60/sh+15,000$9,00022,184 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4